Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
57
pubmed:dateCreated
2002-1-8
pubmed:abstractText
Chronic myeloid leukemia (CML) is characterized by the clonal expansion of hematopoietic stem cells (HSCs). Without effective treatment, individuals in the indolent, chronic phase (CP) of CML undergo blast crisis (BC), the prognosis for which is poor. It is therefore important to clarify the mechanism underlying stage progression in CML. DNA microarray is a versatile tool for such a purpose. However, simple comparison of bone marrow mononuclear cells from individuals at different disease stages is likely to result in the identification of pseudo-positive genes whose change in expression only reflects the different proportions of leukemic blasts in bone marrow. We have therefore compared with DNA microarray the expression profiles of 3456 genes in the purified HSC-like fractions that had been isolated from 13 CML patients and healthy volunteers. Interestingly, expression of the gene for PIASy, a potential inhibitor of STAT (signal transducer and activator of transcription) proteins, was down-regulated in association with stage progression in CML. Furthermore, forced expression of PIASy has induced apoptosis in a CML cell line. These data suggest that microarray analysis with background-matched samples is an efficient approach to identify molecular events underlying the stage progression in CML.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0950-9232
pubmed:author
pubmed:issnType
Print
pubmed:day
13
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8249-57
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11781839-Antigens, CD, pubmed-meshheading:11781839-Apoptosis, pubmed-meshheading:11781839-Carrier Proteins, pubmed-meshheading:11781839-Disease Progression, pubmed-meshheading:11781839-Down-Regulation, pubmed-meshheading:11781839-Gene Expression Profiling, pubmed-meshheading:11781839-Gene Expression Regulation, Neoplastic, pubmed-meshheading:11781839-Genetic Vectors, pubmed-meshheading:11781839-Glycoproteins, pubmed-meshheading:11781839-Hematopoietic Stem Cells, pubmed-meshheading:11781839-Humans, pubmed-meshheading:11781839-Intracellular Signaling Peptides and Proteins, pubmed-meshheading:11781839-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:11781839-Neoplasm Staging, pubmed-meshheading:11781839-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:11781839-Peptides, pubmed-meshheading:11781839-Prognosis, pubmed-meshheading:11781839-Protein Inhibitors of Activated STAT, pubmed-meshheading:11781839-RNA, Neoplasm, pubmed-meshheading:11781839-Retroviridae, pubmed-meshheading:11781839-Tumor Cells, Cultured, pubmed-meshheading:11781839-Up-Regulation
pubmed:year
2001
pubmed:articleTitle
Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells.
pubmed:affiliation
Division of Functional Genomics, Jichi Medical School, Kawachi-gun, Tochigi 329-0498, Japan.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Evaluation Studies